Disposed4

SOLIGENIX, INC.

Total Value

$226.2K

Filing Date

Oct 13, 2026

1 transactions

Trade Summary

On Oct 12, 2026, Guarino Jonathan L., Insider, reported $226.2K of SOLIGENIX, INC. (SNGX) across 1 transactions. The filing covers company securities and reflects balanced net activity of $0. Reported prices ranged from $129.60 to $561.60. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.

Insider Information

Name: Guarino Jonathan L.
Role: Insider
Location: PRINCETON, NJ

Filing Details

Filing Date: Oct 13, 2026
Transaction Date: Oct 12, 2026
Accession Number: 0001787282-26-000002
Form Type: 4

Derivative Transactions

Date	Security	Shares	Exercise Price	Type	Value
Oct 12, 2026	SNGX derivative	166	$232.80	Disposition	$38.6K
Oct 12, 2026	SNGX derivative	41	$297.60	Disposition	$12.2K
Oct 12, 2026	SNGX derivative	166	$561.60	Disposition	$93.2K
Oct 12, 2026	SNGX derivative	208	$187.20	Disposition	$38.9K
Oct 12, 2026	SNGX derivative	333	$129.60	Disposition	$43.2K

Want live alerts when Guarino Jonathan L. trades again?

Download Insider Trades to track SNGX, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.

iOS App Android App

Footnotes

(F1)On October 12, 2026, the Reporting Person voluntarily surrendered stock options exercisable for an aggregate of 914 shares of Common Stock with exercise prices set forth in the table above to the Issuer for cancellation for no consideration. The cancellation is exempt from Section 16(b) of the Exchange Act pursuant to Rule 16b-3(e) and Rule 16b-6(d), and exempt from the reporting requirements of Section 16(a) pursuant to Rule 16a-4(d). The Reporting Person is voluntarily reporting this transaction.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Guarino Jonathan L.

(Last)

(First)

(Middle)

C/O SOLIGENIX, INC.

29 EMMONS DRIVE, SUITE B-10

(Street)

PRINCETON

08540

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
SOLIGENIX, INC. [ SNGX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	CFO

3. Date of Earliest Transaction (Month/Day/Year)
10/12/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Right to Buy)	$232.8	10/12/2026		D⁽¹⁾	V		166	09/09/2019	09/08/2029	Common Stock	166	$0	0	D
Stock Option (Right to Buy)	$297.6	10/12/2026		D	V		41	12/12/2019	12/11/2029	Common Stock	41	$0	0	D
Stock Option (Right to Buy)	$561.6	10/12/2026		D	V		166	12/10/2020	12/09/2030	Common Stock	166	$0	0	D
Stock Option (Right to Buy)	$187.2	10/12/2026		D	V		208	01/21/2022	12/08/2031	Common Stock	208	$0	0	D
Stock Option (Right to Buy)	$129.6	10/12/2026		D	V		333	12/08/2022	12/07/2032	Common Stock	333	$0	0	D

Explanation of Responses:

1. On October 12, 2026, the Reporting Person voluntarily surrendered stock options exercisable for an aggregate of 914 shares of Common Stock with exercise prices set forth in the table above to the Issuer for cancellation for no consideration. The cancellation is exempt from Section 16(b) of the Exchange Act pursuant to Rule 16b-3(e) and Rule 16b-6(d), and exempt from the reporting requirements of Section 16(a) pursuant to Rule 16a-4(d). The Reporting Person is voluntarily reporting this transaction.

	/s/ Jonathan L. Guarino	10/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Form 4 as rendered by the SEC from accession 0001787282-26-000002.

SOLIGENIX, INC.

Trade Summary

Company Information

Insider Information

Filing Details

Derivative Transactions

Want live alerts when Guarino Jonathan L. trades again?

Footnotes

SEC Form 4

SEC Filing

SEC Form 4